Swan-Ganz catheter

Swan-Ganz catheter
Name	Swan-Ganz catheter
Caption	A balloon-tipped, flow-directed catheter
Other names	Pulmonary artery catheter, right heart catheter
Specialty	Critical care medicine, Cardiology, Anesthesiology
Inventor	Harold James Charles Swan, William Ganz
Manufacturer	Edwards Lifesciences
Related	Central venous catheter, Cardiac output monitor

Swan-Ganz catheter. A Swan-Ganz catheter is a specialized thermodilution catheter used for hemodynamic monitoring in critically ill patients. It is a balloon-tipped, flow-directed device that is advanced through the venous system into the pulmonary artery. The primary function is to measure pressures within the right atrium, right ventricle, and pulmonary artery, as well as to estimate cardiac output and other cardiovascular parameters.

History and development

The device was pioneered in the early 1970s by cardiologist Harold James Charles Swan and his colleague, physicist William Ganz, at Cedars-Sinai Medical Center in Los Angeles. Their innovation built upon earlier work with right heart catheterization performed by Werner Forssmann and André Frédéric Cournand. The key advancement was the incorporation of a balloon at the catheter tip, allowing it to be carried by blood flow through the heart chambers, which greatly simplified and increased the safety of placement compared to rigid catheters. The initial clinical trials demonstrated its utility in managing patients after myocardial infarction. The technology was subsequently commercialized through a partnership with Edwards Lifesciences, formerly American Edwards Laboratories.

Indications and clinical use

Traditional indications for placement have included the assessment and management of complex conditions such as cardiogenic shock, septic shock, acute respiratory distress syndrome (ARDS), and severe congestive heart failure. It is frequently used in the settings of cardiac surgery, major trauma, and high-risk obstetric cases. The data obtained guide therapeutic decisions regarding fluid resuscitation, use of inotropic agents and vasopressors, and management of pulmonary edema. Its use was once considered standard in intensive care units like those at the Mayo Clinic and Cleveland Clinic.

Insertion technique and placement

Insertion is typically performed under sterile conditions using the Seldinger technique. The most common access site is the internal jugular vein or subclavian vein. The catheter is advanced through the superior vena cava into the right atrium, where the balloon is inflated. Blood flow then carries the catheter sequentially through the tricuspid valve, into the right ventricle, across the pulmonary valve, and into a branch of the pulmonary artery. Correct positioning is confirmed by observing characteristic pressure waveforms on a monitor, a technique refined through protocols at institutions like Johns Hopkins Hospital.

Measurements and hemodynamic parameters

The catheter directly measures central venous pressure, pulmonary artery pressure, and pulmonary artery wedge pressure, which is an estimate of left atrial pressure. Using the thermodilution method, involving the injection of a cold saline bolus, it calculates cardiac output and cardiac index. Derived parameters include systemic vascular resistance and pulmonary vascular resistance. These measurements provide a comprehensive picture of a patient's ventricular function and fluid status, informing protocols from organizations like the Surviving Sepsis Campaign.

Complications and risks

Procedure-related complications can include pneumothorax, arterial puncture, and hematoma at the insertion site. During advancement, cardiac arrhythmias such as ventricular tachycardia may occur. Longer-term risks include pulmonary artery rupture, a rare but often fatal event, catheter-related bloodstream infection, thrombosis, and valvular damage. The risk of these events prompted increased scrutiny from bodies like the Food and Drug Administration and influenced training requirements from the American Board of Internal Medicine.

Contemporary relevance and alternatives

Following influential studies such as the PAC-Man trial and the ESCAPE trial, which questioned its benefit in improving mortality, the use of the Swan-Ganz catheter has declined significantly. It has been largely supplanted by less invasive monitoring technologies. These alternatives include echocardiography, particularly transesophageal echocardiography, pulse contour analysis devices like the PiCCO system, and esophageal Doppler monitoring. Its role is now often restricted to complex heart failure cases managed at specialized centers like the Texas Heart Institute or during certain procedures like heart transplantation.

Category:Medical equipment Category:Intensive care medicine Category:Cardiology